Company Profile

Illumina Inc
Profile last edited on: 11/13/2023      CAGE: 1WCS2      UEI: KMW3CRWNAAF3

Business Identifier: Tools for large-scale analysis of genetic variation and function.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5200 Illumina Way
San Diego, CA 92122
   (858) 202-4500
Location: Multiple
Congr. District: 50
County: San Diego

Public Profile

Illumina, Inc. (Illumina) was fairly extensively involved in SBIR from very soon after being founded in 1998 until the firm outgrew size requirements by about 2006. However, the firm has maintained strong connections with younger, smaller firms on interest - several being SBIR-involved - establishing various types of working relationship and - in a few cases - actaully acquiring the smaller player. Originally anchored in having secured exclusive worldwide rights to 13 patents and patent applications from Tufts University that were filed by one of the company's directors, Illumina develops and manufactures life science tools and integrated systems for the analysis of genetic variation and function. Organized in two business segments, the Life Sciences and Diagnostics business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. The firm's Diagnostics business unit focuses on molecular diagnostics. Customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 1 NIH $99,160
Project Title: Microfluidic capillary assay utilizing holographically *
2006 2 NIH $1,174,372
Project Title: Representational analysis of DNA copy number/methylation
2006 2 NIH $1,139,664
Project Title: Development of a Multi-State Decoding Framework
2005 2 NIH $1,381,531
Project Title: Protease Substrate Array
2005 2 NIH $1,093,804
Project Title: High-Throughput Methylation Profiling System

Key People / Management

  Jay T Flatley -- President

  Steven M Barnard

  Todd Dickinson

  Jian-Bing Fan

  Kevin L Gunderson

  Semyon Kruglyak

  Michal Lebl

  John A Moon

  Anupama N Srinivasan

  Chanfeng Zhao